Immunosyn Corporation Files 10-Q (abetic ulcers. Immunosyn wentpublic in J...)

Immunosyn Corporation Files 10-Q

Date:5/16/2008

abetic ulcers. Immunosyn went public in January 2007 and its stock began trading on October 26, 2007 on the OTCBB under the symbol "IMYN."

About Immunosyn Corporation

La Jolla, CA-headquartered Immunosyn Corporation (OTC Bulletin Board: IMYN) plans to market and distribute life enhancing therapeutics. Currently, the company has exclusive worldwide rights from its largest shareholder, Argyll Biotechnologies, LLC, to market, sell and distribute SF-1019, a compound that was developed from extensive research into Biological Response Modifiers (BRMs). Argyll Biotechnologies, LLC has initiated the process for regulatory approval of SF-1019 in several countries and preparations for clinical trials are underway in both the US and Europe. Research suggests that SF-1019 has the potential to affect a number of clinical conditions including complications from Diabetic Mellitus such as Diabetic Neuropathy (DN) and diabetic ulcers (DU), auto-immune disorders such as Multiple Sclerosis (MS) and neurological disorders such as Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Reflex Sympathetic Dystrophy Syndrome (RSD or RSDS).

The above news release contains forward-looking statements. These statements are based on assumptions that management believes are reasonable based on currently available information, and include statements regarding the intent, belief or current expectations of the Company and its management. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance, and are subject to a wide range of business risks, external factors and uncertainties. Actual results may differ materially from those indicated by such forward-looking statements. For additional information, please consult the Company's most recent public filings and Annual Report on Form 10-K for its most recent fiscal year. The Company assumes no obligation to update the information contained in this press release, whe
'/>"/>

SOURCE Immunosyn Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related biology technology :

1. Immunosyn Corporation Announces 2007 Results, Files 10KSB
2. USANAs CEO Myron W. Wentz, Ph.D. Has Been Elected to Serve on Immunosyn Corporations Board of Directors
3. Immunosyn Announces Interview of CEO Stephen D. Ferrone by CEOCFO Interviews & News
4. WallSt.net Announces Upcoming Interview With CEO Of Immunosyn Corporation
5. Immunosyn Corporation Names G. David Criner as CFO
6. Immunosyn Corporation to Present at FSX
7. CorVel Corporation Announces Earnings Release Webcast
8. Lentigen Corporation Receives Four Research Grants From the National Institutes of Health
9. Baxa Corporation Wins Two Colorado BMA 2008 Gold Key Awards
10. Pharmos Corporation to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
11. Triple-S Management Corporation Appoints New Non-Executive Chairman to Board; Adds New Director

Post Your Comments:

(Date:12/15/2009)... Reportlinker.com announces that a new market research ... The Future of Orphan Diseases ... Analysis and Reimbursement ,, ... Summary ,, The author has released ... Diseases Therapeutics - Market Forecasts to 2015, ...

(Date:12/15/2009)... Minn., Dec. 15 The Mosaic Company (NYSE: ... fiscal year 2010 earnings results and financial tables on ... on the New York Stock Exchange. Results will ... ,, The Company will host a conference call with ... the results. The call will begin at 11:00 ...

(Date:12/15/2009)... PHILADELPHIA and LONDON, Dec. 15 ... Thomson Pharma ® has become the first ... trial protocol and outcome information. This highly anticipated ... Pharma customers this month. ,, ... trial intelligence from registries, publications, press releases, conferences, ...

(Date:12/14/2009)... -- Vermillion, Inc. (Pink Sheets: VRML), a ... Wallen, Ph.D. Chief Scientific Officer, Senior Vice ... will be joining its board of directors ... ,, "Bill brings more than 20 years ... biotechnology," said Gail Page, Vermillion Executive Chairperson. ...

[0] Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement [0] Mosaic Announces Second Quarter Fiscal Year 2010 Earnings Release and Conference Call [0] Thomson Reuters is First to Offer Fully Integrated Pipeline and Clinical Trials [0] Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors

... BEDMINSTER, N.J., Feb. 29 NPS,Pharmaceuticals, Inc. (Nasdaq: ... executive vice president, chief operating officer, and chief,executive ... Brothers,Eleventh Annual Global Healthcare Conference in Miami on ... presentation will be available as a live,webcast with ...

... Kendle (Nasdaq: KNDL ), a,leading, ... Vice President and Chief Marketing Officer Simon,Higginbotham ... James,Institutional Investors Conference. The conference will be ... Orlando, March 2-5, 2008. Kendle,s,presentation is scheduled ...

... Tests Based on Company,s microRNA ... Technology on Schedule for 2008, REHOVOT, Israel and ... ROSG ), a leading,molecular diagnostics company, today reported a narrower operating ... corresponding,period of 2006, and said it remains solidly on target for ...

NPS Pharmaceuticals to Present at the Lehman Brothers Eleventh Annual Global Healthcare Conference Kendle to Present at the 29th Annual Raymond James Institutional Investors Conference Rosetta Genomics Reports Fourth-Quarter and Full-Year 2007 Financial Results

(Date:12/16/2009)... Tom Bowman, an expert in communicating scientific issues to ... developed a series of graphics that translate key figures ... report for public audiences. These new graphics provide non-experts ... make informed decisions about climate change risks and opportunities. ... to clearly and accurately communicate findings in the IPCC ...

(Date:12/16/2009)... 1 iQor, a global provider of business ... InfoWorld 100 Awards Top 100 IT project ... was the first submission for iQor. ,, "We are ... companies," said Vikas Kapoor, president and CEO of iQor. ... allowing us to work faster, smarter and with the ...

(Date:12/16/2009)... REDWOOD CITY, Calif., Dec. 2 ... and authentication solutions, today announced an agreement ... of its DigitalPersona biometric fingerprint technology on ... U.are.U® 4500HD offering allows point-of-sale applications to ... that specific transactions can be linked to ...

Breaking Biology News(10 mins):Bowman creates graphic translation of climate change data 2 iQor Named to InfoWorld 100 List of Top IT Projects of 2009 2 DigitalPersona Fingerprint Sensor Technology Ships on IBM SurePOS 500 Retail Systems 2 Injection Reverses Heart Attack Damage 4771 1 Injection Reverses Heart Attack Damage 4771 2 Injection Reverses Heart Attack Damage 4771 3 Injection May Heal Damaged Heart 52560 1 Injection May Heal Damaged Heart 52560 2 International Health Leaders to Share Innovations in Patient Centered Care at 2009 Planetree Annual Conference 52555 1 International Health Leaders to Share Innovations in Patient Centered Care at 2009 Planetree Annual Conference 52555 2 International Health Leaders to Share Innovations in Patient Centered Care at 2009 Planetree Annual Conference 52555 3

[0] Bowman creates graphic translation of climate change data [0] iQor Named to InfoWorld 100 List of Top IT Projects of 2009 [0] DigitalPersona Fingerprint Sensor Technology Ships on IBM SurePOS 500 Retail Systems

... cancer survivors might one day avoid the prospect of ... that would involve using stem cells derived from their ... studying the potential these cells may have for regenerating ... researchers hope to prove that an injection of fat-derived ...

... response to higher global temperatures may be somewhat overstated ... to adjust to changing conditions, according to researchers from ... published April 28 by Science, a team led by ... percent more carbon will be stored in plants and ...

... A jumping gene first identified in a cabbage-eating moth may ... gene therapy, researchers say. , , They compared the ... insert themselves into a cell's DNA and produce a desired ... radiation therapy. , They found the piggyBac transposon was five ...

Other Biology News:Fat stem cells being studied as option for breast reconstruction 2 Plants' role in global warming re-examined 2 Jumping gene could provide non-viral alternative for gene therapy 2 Jumping gene could provide non-viral alternative for gene therapy 3

Fat stem cells being studied as option for breast reconstruction Plants' role in global warming re-examined Jumping gene could provide non-viral alternative for gene therapy

One-step, microplate or cuvet, colorimetric, detection range 0.01 g/dL to 5 g/dL. Procedure: 5 min....

MOUSE ANTI PROTEIN KINASE C BETA 2 Immunogen: Protein kinase C beta 2...

SHEEP ANTI DEHYDROEPIANDROSTERONE...

This issue concentrated on the purification of proteins for specific purposes (i.e. large-scale purification, purification for therapeutic use, etc.)...

Biology Products:

Albumin Colorimetric Assay Kit, QuantiChrom from BioAssay Systems Mouse Anti-Protein Kinase C Beta 2 Monoclonal Antibody, Unconjugated from AbD Serotec Sheep Anti-DEHYDROEPIANDROSTERONE (+DEAHS) Polyclonal Antibody, Unconjugated from AbD Serotec Protein Purification Applications from Promega

Immunosyn Corporation Files 10-Q(abetic ulcers. Immunosyn wentpublic in J...)